3. Wu L, Liu C, Chang DY, Zhan R, Sun J, Cui SH, Eddy S, Nair V, Tanner E, Brosius FC, Looker HC, Nelson RG, Kretzler M, Wang JC, Xu M, Ju W, Zhao MH, Chen M, Zheng L. 2021; Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney Int. 100:107–121. Erratum in:
Kidney Int. 2021;100:1349-1350. DOI:
10.1016/j.kint.2021.02.025. PMID:
33675846. PMCID:
PMC8893600. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104313122&origin=inward.
Article
7. Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z, Lin Y, Bai X, Liu X, Chen X, Yang H, Xu C, Zhang Y, Yang B. 2018; Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis. 9:171. DOI:
10.1038/s41419-017-0257-3. PMID:
29416034. PMCID:
PMC5833729. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041693664&origin=inward.
Article
9. Xia S, Zhang Z, Magupalli VG, Pablo JL, Dong Y, Vora SM, Wang L, Fu TM, Jacobson MP, Greka A, Lieberman J, Ruan J, Wu H. 2021; Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature. 593:607–611. DOI:
10.1038/s41586-021-03478-3. PMID:
33883744. PMCID:
PMC8588876. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104775814&origin=inward.
Article
11. Gu J, Huang W, Zhang W, Zhao T, Gao C, Gan W, Rao M, Chen Q, Guo M, Xu Y, Xu YH. 2019; Sodium butyrate alleviates high-glucose-induced renal glomerular endothelial cells damage via inhibiting pyroptosis. Int Immunopharmacol. 75:105832. DOI:
10.1016/j.intimp.2019.105832. PMID:
31473434. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85071400890&origin=inward.
Article
19. Wang Y, Zhu X, Yuan S, Wen S, Liu X, Wang C, Qu Z, Li J, Liu H, Sun L, Liu F. 2019; TLR4/NF-κB signaling induces GSDMD-related pyroptosis in tubular cells in diabetic kidney disease. Front Endocrinol (Lausanne). 10:603. DOI:
10.3389/fendo.2019.00603. PMID:
31608008. PMCID:
PMC6761221. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072989012&origin=inward.
Article
22. Yan L, Xie X, Niu BX, Wu MT, Tong WQ, He SY, Huang CY, Zhao WC, Li G, Li NS, Jiang JL. 2021; Involvement of miR-199a-3p/DDR1 in vascular endothelial cell senescence in diabetes. Eur J Pharmacol. 908:174317. DOI:
10.1016/j.ejphar.2021.174317. PMID:
34270989. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85110319625&origin=inward.
Article
23. Kerroch M, Guerrot D, Vandermeersch S, Placier S, Mesnard L, Jouanneau C, Rondeau E, Ronco P, Boffa JJ, Chatziantoniou C, Dussaule JC. 2012; Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. FASEB J. 26:4079–4091. DOI:
10.1096/fj.11-194902. PMID:
22751008. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84868089019&origin=inward.
Article
25. Kwon G, Uddin MJ, Lee G, Jiang S, Cho A, Lee JH, Lee SR, Bae YS, Moon SH, Lee SJ, Cha DR, Ha H. 2017; A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis. Oncotarget. 8:74217–74232. DOI:
10.18632/oncotarget.18540. PMID:
29088780. PMCID:
PMC5650335. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85030100536&origin=inward.
Article
34. Malaguarnera R, Nicolosi ML, Sacco A, Morcavallo A, Vella V, Voci C, Spatuzza M, Xu SQ, Iozzo RV, Vigneri R, Morrione A, Belfiore A. 2015; Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses. Oncotarget. 6:16084–16105. DOI:
10.18632/oncotarget.3177. PMID:
25840417. PMCID:
PMC4599258. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84937836761&origin=inward.
Article
35. Matà R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A. 2016; IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway. Oncotarget. 7:7683–7700. DOI:
10.18632/oncotarget.6524. PMID:
26655502. PMCID:
PMC4884947. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84958817630&origin=inward.
Article
37. Moll S, Yasui Y, Abed A, Murata T, Shimada H, Maeda A, Fukushima N, Kanamori M, Uhles S, Badi L, Cagarelli T, Formentini I, Drawnel F, Georges G, Bergauer T, Gasser R, Bonfil RD, Fridman R, Richter H, Funk J, et al. 2018; Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime. J Transl Med. 16:148. DOI:
10.1186/s12967-018-1524-5. PMID:
29859097. PMCID:
PMC5984769. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85047970806&origin=inward.
Article
43. Yi H, Peng R, Zhang LY, Sun Y, Peng HM, Liu HD, Yu LJ, Li AL, Zhang YJ, Jiang WH, Zhang Z. 2017; LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy. Cell Death Dis. 8:e2583. DOI:
10.1038/cddis.2016.451. PMID:
28151474. PMCID:
PMC5386454. PMID:
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85011578559&origin=inward.
Article